Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer

Gene Therapy

Volumn 6, Issue 5, 1999, Pages 854-864

  Anderson, L M ^a   Swaminathan, S ^a   Zackon, I ^a   Tajuddin, A K ^a   Thimmapaya, B ^a   Weitzman, S A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adenoviral vectors; Breast cancer; Gene therapy; Tissue specificity

Indexed keywords

ALPHA LACTALBUMIN; BETA GALACTOSIDASE; BETA LACTOGLOBULIN; GANCICLOVIR; THYMIDINE KINASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER SURVIVAL; CELL SPECIFICITY; CONTROLLED STUDY; FEMALE; GENE TARGETING; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NUDE MOUSE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SUICIDE GENE; VIRUS GENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; HERPES; MINK CELL FOCUS-FORMING VIRUS; MUS MUSCULUS; OVIS; SIMPLEXVIRUS;

EID: 0032981048     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300909     Document Type: Article

References (34)

1. Weichselbaum R, Kufe D. Gene therapy of cancer. Lancet 1997; 349: SII10-SII102.
2. Miller N, Whelan J. Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum Gene Ther 1997; 8: 803-815.
3. Shirakawa T, Sung-Chu K, Gardner TA, Jun C, Tadayuki M, Gotoh A, Chung LWK, Kao C. In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy. Cancer Gene Ther 1998; 5: 274-280.
4. Cohen C, Sharkey FE, Shulman G, Uthman E, Budgeon L. Tumor-associated antigens in breast carcinomas. Cancer 1987; 60: 1294-1298.
5. De Almeida PC, Pestana CB. Immunohistochemical markers in the identification of metastic breast cancer. Breast Cancer Res Treat 1992; 21: 201-210.
6. Thean ET, Toh B. Serum human alpha-lactalbumin as a marker for breast cancer. Br J Cancer 1990; 61: 773-775.
7. Lee AK, Delellis RA, Rosen PP, Herbert-Stanton T, Tallberg K, Garcia C, Wolfe H. Alpha-lactalbumin as an immunohistochemical marker for metastatic breast carcinomas. Am J Surg Pathol 1984; 8: 93-100.
8. Collette J, Hendrick JC, Jaspar J, Franchimont P. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15 000 daltons) in breast cyst fluid. Cancer Res 1986; 46: 3728-3733.
9. Simickova M, Lang BA, Rejthar A, Cernoch M, Sakalovk J, Pacovsky Z. Immunohistochemical localization of alpha-lactalbumin in human breast cancer tissue. Neoplasma 1989; 36: 11-20.
10. Walker RA. The demonstration of alpha-lactalbumin in human breast carcinomas. J Pathol 1979; 129: 37-42.
11. Eden JA, Wren BG. Hormone replacement therapy: a review. Cancer Treat Rev 1996; 22: 335-343.
12. Findlay J, Brew K. The complete amino acid sequence of human alpha-lactalbumin. Eur J Biochem 1972; 27: 65-86.
13. Quirk SJ, Gannell JE, Funder JW. Alpha-lactalbumin production by rat mammary gland: prepartum emergence of resistance to glucocorticoids and progestins. Mol Cell Biol 1988; 58: 183-189.
14. Maschio A et al. Transgenic mice carrying the guinea-pig alpha-lactalbumin gene transcribe milk protein genes in their sebaceous glands during lactation. Biochem J 1991; 275: 459-467.
15. Stacy A et al. Use of double-replacment gene targeting to replace the murine ALA gene with its human counterpart in embryonic stem cells and mice. Mol Cell Biol. 1994; 14: 1009-1016.
16. Stacy A et al. Lactation is disrupted by alpha-lactalbumin deficiency and can be restored by human alpha-lactalbumin gene replacement in mice. Prac Natl Acad Sci USA. 1995; 92: 2835-2839.
17. Moolten FL, Wells M. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 1990; 82: 297-300.
18. Ali S, Clark J. Characterization of the gene encoding ovine beta-lactoglobulin: similarity to the genes for retinol binding protein and secretory proteins. J Mol Biol 1988; 199: 415-426.
19. Ali S, McClenaghan M, Simons PJ, Clark JA. Characterization of the alleles encoding ovine beta-lactoglobulins A and B. J Mol Biol 1990; 91: 201-207.
20. Mink S et al. A mammary cell-specific enhancer in mouse mammary tumor virus DNA is composed of multiple regulatory elements including binding sites for CTF/NFI and a novel transcription factor, mammary cell-activating factor. Mol Cell Biol 1992; 12: 4906-4918.
21. Brace C et al. Position-independent expression of the ovine beta-lactoglobulin gene in transgenic mice. Biochem J 1992; 286: 31-39.
22. Mercier JC, Vilotte JL. Structure and function of milk protein genes. J Dairy Sci 1993; 76: 3079-3098.
23. Harris S et al. Developmental regulation of the sheep beta-lactoglobulin gene in the mammary gland of transgenic mice. Dev Genet 1991; 12: 299-307.
24. Curiel DT, Pilewski JM, Albelda SM. Gene therapy approaches for inherited and acquired lung diseases. Am J Respir Cell Mol Biol 1996; 14: 1-18.
25. Esandi MC et al. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene. Gene Therapy 1997; 4: 280-287.
26. Connelly S et al. Complete short-term correction of canine hemophilia A by in vivo gene therapy. Blood 1996; 88: 3846-3853.
27. Chen SH et al. Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. Cancer Res 1996; 56: 3758-3762.
28. Zhu N, Liggitt D, Liu Y, Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993; 261: 209-211.
29. Kass-Eisler A et al. The impact of developmental stage, route of injection and the immune system on adenovirus-mediated gene transfer. Gene Therapy 1994; 1: 395-402.
30. Smiley RS et al. Establishment of parameters for optimal transduction efficiency and antitumor effects with purified high-titer HSVtk retroviral vector in established solid rumors. Hum Gene Ther 1997; 8: 965-977.
31. Stow ND. Cloning of a DNA fragment from the left-hand terminus of the adenovirus type 2 genome and its use in site-directed mutagenesis. J Virol 1981; 37: 171-180.
32. Swaminathan S, Thimmapaya B. Transactivation of adenovirus E2-early promoter by E1a and E4 6/7 in the context of the viral chromosome. J Mol Biol 1996; 258: 736-746.
33. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ (ed). Gene Transfer and Expression Protocols. Humana Press: New York, 1991 pp 109-128.
34. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.